The Canadian Cancer Research Alliance (CCRA) is an alliance of organizations that collectively fund most of the cancer research conducted in Canada – research that will lead to:

  • better ways to prevent cancer
  • diagnose cancer
  • treat cancer and
  • improve patient and survivor outcomes.

Members include federal research funding programs/agencies, provincial research agencies, provincial cancer care agencies, cancer charities, and other voluntary associations. 

We are motivated by the belief that, through effective collaboration, Canadian cancer research funding organizations can maximize their collective impact on cancer control and accelerate discovery for the ultimate benefit of Canadians affected by cancer.

Our Executive Office is supported by the Canadian Partnership Against Cancer, an independent, not-for-profit organization funded by the federal government to accelerate action on cancer control for all Canadians. For more information on the Partnership’s role, click here.

The CCRA is not a registered charity and cannot accept donations. If you wish to donate to a charity that funds cancer research, please check our Members page.


  • has been publishing reports on the annual investment in cancer research in Canada since 2007 (to access, click here)
  • also publishes research investment reports on childhood and adolescent cancers, cancer risk and prevention, early translation, survivorship, and palliative and end-of-life care (to access, click here)
  • has developed two pan-Canadian cancer research strategies, which identify key priorities for cancer research funding collaboration (to access, click here)
  • has produced specific research frameworks for prevention, survivorship, and palliative and end-of-life care, as well as a report on the state of cancer clinical trials in Canada (to access, click here)
  • CCRA’s publications have been cited in more than 50 scientific papers (for a listing of these papers, click here)
  • has convened three scientific conferences, with the fourth scheduled for November 2017 in Vancouver (for more information, click here)
  • recognizes, on a biennial basis, the accomplishments of key leaders in cancer research (for more information, click here).

Call for Nominations for 2019 CCRA Awards

In 2011, the CCRA initiated a biennial recognition program consisting of three awards to acknowledge and celebrate the contributions of individuals who have had a remarkable impact on cancer research and the cancer research community. In 2017, the CCRA announced a new award recognizing exceptional leadership in patient involvement in cancer research. These awards are presented during the Canadian Cancer Research Conference.

To submit a nomination, please provide the nominee’s name and a brief paragraph detailing the reasons for nomination to Diana Soifer (This email address is being protected from spambots. You need JavaScript enabled to view it.) by the end of day on May 15, 2019. Nominations are open to all, including past nominees.

Dr. Cindy Bell is CCRA's New Chair

At the December 2018 CCRA Member Meeting, Dr. Cindy Bell, Genome Canada's Executive Vice-President, Corporate Development, transitioned from Chair-elect to CCRA Chair. Dr. Bell was elected from among the organizational representatives and will serve a two-year term.

Members recognized the invaluable contributions of outgoing Chair, Dr. Stephen Robbins, Scientific Director, CIHR Institute of Cancer Research. Dr. Robbins will remain in the Past-Chair capacity until December 2019.

Hot off the press!

The recently released 2017-18 annual report of the Canadian Cancer Clinical Trials Network (3CTN) summarizes the accomplishments of the 3CTN cancer centres and represents the culmination of its initial four year strategic plan spanning 2014-2018. The report provides many examples of how 3CTN has established a sustained framework for supporting Canada’s academic cancer clinical trials environment, setting a foundation for the future.

New Scientific Partner of CPTP

The University of Toronto’s Dalla Lana School of Public Health will be the new scientific partner of Canadian Partnership for Tomorrow Project (CPTP), Canada’s largest-ever health research platform. The University of Toronto, working in partnership with the Ontario Institute for Cancer Research, will accelerate CPTP’s research potential and provide more opportunities for made-in-Canada discoveries. The Dalla Lana School of Public Health was selected for its strong track record of world class public health and extensive experience leading large-scale studies.

Coordinated nationally through the Canadian Partnership Against Cancer and now the Dalla Lana School of Public Health, CPTP is the result of a decade of collaboration among scientific leaders across the country: BC Generations Project, Alberta’s Tomorrow Project, Ontario Health Study, Quebec’s CARTaGENE project, Atlantic PATH, and CPTP’s newest emerging cohort, the Manitoba Tomorrow Project. The new leadership team, Dr. Philip Awadalla as National Scientific Director and John McLaughlin as Executive Director, is committed to continuing the unprecedented pan-Canadian collaboration among the regional cohorts.

With health and biological information from over 300,000 Canadians aged 30 to 74, CPTP will remain a valuable international and national research tool, allowing scientists to further explore how genetics, environment, lifestyle and behaviour interact and contribute to the development of cancer and other chronic diseases. For more information, see

Other News and Events...

LeadAction|Breast Cancer du Sein Competition

On February 4th, World Cancer Day, IRICoR (Institute for Research in Immunology and Cancer - Commercialization of Research) and the Quebec Breast Cancer Foundation (QBCF) launched the LeadAction|Breast Cancer du Sein. This new partnership aims to accelerate the discovery of new treatments to be accessible to patients. The Competition’s total budget allocation of $3M ($1.5M from IRICoR and $1.5M from the QBCF) will be dedicated to fund innovative breast cancer research projects, from Quebec and the rest of Canada. The projects selected will be announced in the fall of 2019. For more information, please go to the LeadAction|Breast Cancer du Sein Competition page.